CIBC World Market’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.2M Sell
550,628
-149,546
-21% -$7.09M 0.03% 256
2025
Q4
$35.6M Buy
700,174
+145,527
+26% +$7.44M 0.06% 190
2025
Q3
$30.8M Sell
554,647
-99,416
-15% -$5.82M 0.06% 200
2025
Q2
$45.1M Buy
654,063
+8,400
+1% +$571K 0.09% 137
2025
Q1
$44.8M Sell
645,663
-12,800
-2% -$1.06M 0.1% 134
2024
Q4
$56.6M Buy
658,463
+38,689
+6% +$4.18M 0.12% 115
2024
Q3
$73.8M Buy
619,774
+120,378
+24% +$16.1M 0.15% 99
2024
Q2
$71.3M Buy
499,396
+113,136
+29% +$15M 0.16% 93
2024
Q1
$49.6M Buy
386,260
+35,810
+10% +$4.26M 0.12% 108
2023
Q4
$36.3M Sell
350,450
-11,070
-3% -$1.09M 0.09% 134
2023
Q3
$32.9M Buy
361,520
+13,180
+4% +$1.16M 0.11% 129
2023
Q2
$28.2M Sell
348,340
-23,868
-6% -$1.95M 0.09% 146
2023
Q1
$29.6M Buy
372,208
+63,294
+20% +$4.49M 0.1% 139
2022
Q4
$20.9M Buy
308,914
+85,458
+38% +$5.01M 0.07% 159
2022
Q3
$11.1M Sell
223,456
-71,910
-24% -$3.85M 0.04% 217
2022
Q2
$16.5M Buy
295,366
+27,546
+10% +$1.53M 0.06% 179
2022
Q1
$14.9M Sell
267,820
-34,810
-12% -$1.79M 0.05% 200
2021
Q4
$16.9M Sell
302,630
-5,376
-2% -$291K 0.05% 196
2021
Q3
$14.8M Buy
308,006
+73,666
+31% +$3.56M 0.05% 196
2021
Q2
$9.81M Sell
234,340
-12,488
-5% -$484K 0.03% 253
2021
Q1
$8.32M Buy
246,828
+39,078
+19% +$1.39M 0.02% 276
2020
Q4
$7.26M Buy
207,750
+27,026
+15% +$934K 0.02% 278
2020
Q3
$6.27M Sell
180,724
-9,076
-5% -$303K 0.03% 260
2020
Q2
$6.21M Sell
189,800
-108,954
-36% -$3.48M 0.03% 256
2020
Q1
$8.99M Sell
298,754
-32,438
-10% -$966K 0.05% 183
2019
Q4
$9.59M Buy
331,192
+14,062
+4% +$389K 0.04% 213
2019
Q3
$8.2M Sell
317,130
-11,544
-4% -$292K 0.04% 211
2019
Q2
$8.39M Sell
328,674
-46,124
-12% -$1.14M 0.04% 207
2019
Q1
$9.8M Buy
374,798
+121,622
+48% +$2.99M 0.05% 191
2018
Q4
$5.83M Buy
253,176
+9,286
+4% +$206K 0.03% 241
2018
Q3
$5.75M Buy
243,890
+15,386
+7% +$375K 0.02% 275
2018
Q2
$5.27M Buy
228,504
+15,206
+7% +$361K 0.02% 282
2018
Q1
$5.25M Buy
+213,298
New +$5.6M 0.02% 284
2017
Q3
Sell
-380,658
Closed -$8.16M 983
2017
Q2
$8.16M Buy
380,658
+72,374
+23% +$1.46M 0.03% 228
2017
Q1
$5.28M Buy
308,284
+43,786
+17% +$762K 0.02% 268
2016
Q4
$4.74M Buy
264,498
+147,984
+127% +$2.68M 0.02% 252
2016
Q3
$2.42M Buy
116,514
+10,320
+10% +$256K 0.01% 322
2016
Q2
$2.86M Buy
106,194
+39,516
+59% +$1.08M 0.01% 276
2016
Q1
$1.81M Sell
66,678
-201,238
-75% -$5.39M 0.01% 325
2015
Q4
$7.78M Buy
267,916
+124,674
+87% +$3.45M 0.04% 121
2015
Q3
$3.88M Buy
143,242
+18,114
+14% +$513K 0.02% 205
2015
Q2
$3.43M Buy
125,128
+4,618
+4% +$130K 0.01% 240
2015
Q1
$3.22M Buy
120,510
+72,656
+152% +$1.67M 0.01% 224
2014
Q4
$1.01M Buy
47,854
+3,020
+7% +$67.5K ﹤0.01% 442
2014
Q3
$1.07M Buy
44,834
+11,000
+33% +$253K ﹤0.01% 387
2014
Q2
$781K Sell
33,834
-177,954
-84% -$3.93M ﹤0.01% 455
2014
Q1
$4.83M Buy
+211,788
New +$4.51M 0.02% 142
2013
Q4
Sell
-47,690
Closed -$807K 690
2013
Q3
$807K Buy
47,690
+22,290
+88% +$375K ﹤0.01% 359
2013
Q2
$394K Buy
+25,400
New +$423K ﹤0.01% 435

Other funds holding NVO

CIBC World Market's NVO Position: Q1 2026 in Review

CIBC World Market reduced its Novo Nordisk (NVO) stake by 21% in Q1 2026, selling an estimated $7.09M and leaving 550,628 shares worth $20.2M. The position accounts for 0.03% of the portfolio, ranked #256.

CIBC World Market first reported a position in NVO in Q2 2013 and has held it in 49 quarters since. The position peaked at $73.8M in Q3 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • CIBC World Market held 550,628 shares of Novo Nordisk worth $20.2M as of Q1 2026.
  • CIBC World Market sold 149,546 Novo Nordisk shares in Q1 2026, an estimated $7.09M.
  • Novo Nordisk made up 0.03% of CIBC World Market's portfolio in Q1 2026, its #256 holding.
  • CIBC World Market first reported a position in Novo Nordisk in Q2 2013 and has held it in 49 quarters since.
  • CIBC World Market's Novo Nordisk position peaked at $73.8M in Q3 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on CIBC World Market's 13F filing for Q1 2026, filed 14 May 2026.